VivaDiag™ SARS-CoV-2/Flu A/Flu B Ag Rapid Check is for the simultaneous detection and differentiation of the antigens from SARS-CoV-2, influenza A and influenza B within the specimens from individuals suspected of respiratory viral infections.The check will function a robust weapon for the healthcare professionals to combat against the COVID 19 pandemic.
“The need for rapid take a look at kits is very robust now that we’re seeing a rise in COVID-19 outbreaks and because the U.S. continues to open up,” said David Yoo, CEO of GenBody America. “We are excited to supply the GenBody COVID-19 Ag take a look at to the U.S. and we’re looking ahead to bringing additional product releases to market.”
Diagnostic efficiency of monocyte distribution width and different leukocyte parameters for SARS-CoV-2 and influenza infection
The affect of SARS-CoV-2 nucleocapsid protein mutations on the efficiency of fast apa itu swab test antigen for sale assessments
The enigma of submit-acute infection syndromes
Thompson is the senior author on the research and a main-care physician at UW Drugs.